Auditory neuropathy (AN) is a hearing disorder characterized by an abnormal auditory brainstem response (ABR). This study examined experimental AN model induced in mice following increased dosages of pyridoxine. Induced AN was examined for Յ10 weeks following the last pyridoxine treatment. To assess AN, we evaluated the ABR, auditory middle latency response (AMLR), otoacoustic emission (OAE), and histochemical morphology of the auditory nerve. Pyridoxine-treated mice exhibited an increase in the hearing threshold shift and delayed latency of both ABR and AMLR in proportion to pyridoxine dosage. Additionally, the extent of auditory nerve fiber loss increased in a dose-dependent manner following pyridoxine intoxication. Coffee or trigonelline treatment ameliorated the hearing threshold shift, delayed latency of the auditory evoked potential, and improved sensory fiber loss induced by pyridoxine intoxication. The present findings demonstrate that high-dose pyridoxine administration can be used to produce a new mouse model for AN, and coffee or trigonelline as a main active compound of coffee extract can potentially facilitate recovery from pyridoxine-induced auditory neuropathy.
Auditory neuropathy (AN), a hearing disorder characterized by the presence of otoacoustic emissions (OAEs) in combination with an abnormal or absent auditory brainstem response (ABR), 1) is considered to cause severe impairment of intensity-related perception, including loudness discrimination, pitch discrimination at high frequencies, and sound localization based on interaural-level differences. [2] [3] [4] The pathology underlying AN is not yet known, but because myelin disorders may disrupt neural synchrony and produce impairment in temporal encoding, primary demyelination of the auditory nerve is one of the proposed pathological mechanisms. 5) The auditory nerve is a component of the vestibulocochlear nerve, the eighth cranial nerve, and conducts electrical impulses from the cochlea to the brainstem. 6) Many nerve axons in the mammalian nervous system are myelinated along most of their length, speeding neural transmission. 7) The absence of myelin during development or neural pathologies leading to demyelination or myelin disruption can slow conduction along such nerves and may lead to complete conduction block. 8) The ABR and the auditory middle latency response (AMLR) can be used as hearing sensitivity and neurological screening tests to assess the integrity of the peripheral auditory nerve and the higher central auditory nervous system. OAEs are faint sounds emitted by the cochlea, either spontaneously or in response to an acoustic signal. 9) OAEs are considered responses of cochlear origin generated when the cochlea is functioning normally, and their close relationship with the nonlinear micromechanics of outer hair cells (OHCs) is well established. 10, 11) Pyridoxine, or vitamin B6, a vitamin popularly used as a food supplementation or a medicine, has been reported one of the causes of peripheral neuropathy. Schaumburg 12) et al. reported a severe sensory neuropathy having an insidious onset and course that was associated with chronic abuse of oral pyridoxine supplements. Compelling evidence related to the functional and physiological parameters induced by pyri-doxine neurotoxicity has been obtained in dogs, 13) rodents, 14) and humans. 15) However, the hearing impairment resulting from pyridoxine intake at excessive dosages has yet to be documented and the mechanism of pyridoxine toxicity is unknown.
Coffee is one of the most highly consumed beverages in the world. Although some people avoid drinking coffee due to the health risks it poses, several recent studies have shown that coffee reduces the risks for developing Alzheimer's disease, 16) type 2 diabetes, 17) gallstones, 18) and colon cancer 19) and improves cognitive performance. 20, 21) Recently, we reported that coffee or trigonelline, a main active component of coffee extract, prevents hearing impairment with hearing threshold shifts and delayed latencies resulting from diabetic auditory neuropathy. 22) The aim of this study was to show the creation of a new AN mouse model induced by high dosages of pyridoxine and the protective action of coffee or trigonelline on this condition in a mouse model. To assess the resulting AN, we compared each of the following parameters: auditory evoked potentials (AEPs) and OAEs for evaluation of cochlear functioning, the auditory nerve and the central auditory pathway impairment following treatment, and the histochemical morphology of the auditory nerve.
MATERIALS AND METHODS
Coffee extract was prepared from Coffea arabica (Brazil) supplied by Dongsuh Co., Ltd. (Seoul, Korea). Roasted coffee beans (600 g) were extracted with distilled water at 70°C for 2 h. Following filtration, the solution was evaporated in vacuo and lyophilized. The dried extract (88 g) was used as the coffee sample in the experiment. Trigonelline and caffeine as analytical standards were analyzed in the coffee sample by HPLC. HPLC analysis was performed as described by Casal et al. 23) with an analytical HPLC unit (Shimadzu Co., Japan). A reversed-phase Spherisorb ODS2 (5 mm particle size, 25.0ϫ0.46 cm) column was used. The solvent system used was a gradient of phosphate buffer pH 4.0 (0.1 M) and acetonitrile performed at a constant flow rate of 1.0 ml/min at 40°C. Detection was accomplished with a UV-vis detector at 265 nm ( Fig. 1 ).
Adult male ICR mice aged 7 weeks (Jung-Ang Lab Animal, Seoul, Korea) were used in this study. The mice were housed under a 12 h/12 h light/dark cycle, with food and water ad libitum. All experimental procedures were performed in accordance with the Principles of Laboratory Animal Care (NIH publication, #80-23, revised in 1996) and the Animal Care and Use Guidelines of Nambu University, Korea. Mice were divided into six groups (nϭ10/group), including a no pyridoxine treatment group (Normal), pyridoxine 175 mg/kg treatment group (Py-175), pyridoxine 350 mg/kg treatment group (Py-350), pyridoxine 700 mg/kg treatment group (Py-700), pyridoxine 350 mg/kg and coffee 300 mg/kg treatment group (Py-Coffee), and pyridoxine 350 mg/kg and trigonelline (Sigma Co., St. Louis, MO, U.S.A.) 10 mg/kg treatment group (Py-TRG). Pyridoxine was administered intraperitoneally twice/d for 14 d. The pyridoxine-treated mice were subjected to an auditory electrophysiological test at 0, 5, 6, 7, 8, 9, and 10 weeks after the final pyridoxine administration. Coffee and trigonelline were administrated per os once/d, beginning 5 weeks after the final pyridoxine administration.
Auditory function tests were performed for the mice under anesthesia with xylazine (0.43 mg/kg) and ketamine (4.57 mg/kg) administered intramuscularly. The rectal temperature was maintained at 37Ϯ0.5°C using a heating lamp at the time of testing. Peripheral and midbrain auditory functions were determined based on ABR and AMLR using twochannel recordings (GSI Audera, Viasys Healthcare Inc., U.S.A.). For ABR recordings, alternating clicks (0.1-ms duration) and 8-kHz tone bursts (TBs) (rise-plateau-fall; 2-1-2 cycles) were delivered via earphones (Etymotic ER-3A) at a rate of 20.1 stimuli/s. Physiological filters were set to pass electrical activity between 100 and 3000 Hz. The average for 1000 sweeps was determined in a 10.24-ms time window. Parameters of ABR were evaluated based on the hearing threshold and the interpeak latency of waves I-IV. For AMLR measurements, rarefaction clicks (0.1-ms duration) were delivered via earphones at a rate of 9.1 stimuli/s. Filters were set to pass activity between 10 and 250 Hz. The average for 250 sweeps was determined in a 70-ms time window. The parameter of AMLR was evaluated with absolute latencies of wave positive peak A (Pa).
The function of OHCs in the cochlear was determined based on transient evoked otoacoustic emissions (TEOAEs) using ILO v6 (Otodynamics Co., Ltd., U.K.). TEOAEs were evoked by a 80-ms click of an intensity 80 dB SPL, according to the standard non-linear ILO protocol. TEOAE responses were evaluated in the frequency domain (FFT), by estimating signal intensity to noise at 3 and 4 kHz. At 10 weeks following pyridoxine intoxication, the anesthetized mice of Normal, Py-350, Py-Coffee, and Py-TRG groups were decapitated and the auditory nerve was rapidly excised. The auditory nerve was immersed in a fixative and incubated at 4°C for Ն12 h. The specimens were immersed in 2% osmium tetroxide in 0.1 M phosphate buffer for at 4°C 2 h, dehydrated through a graded series of ethanol solutions, the final solution being 100% ethanol, and embedded in Epon 812. Following polymerization, ultrathin sections (50-60 nm) were cut and stained with uranyl acetate and lead citrate. The histochemical morphology of the auditory nerve was observed under a transmission electron microscope (TEM; H7100, Hitachi, Japan).
The data were analyzed using SigmaPlot software (Systat Software Inc., Chicago, IL, U.S.A.). All data are expressed as the meanϮstandard error of the mean (S.E.M.). Statistically significant differences in threshold shifts, latency delays, and response intensities among treatment groups and test points were tested via ANOVA. When a major effect was found, Tukey's post hoc test was performed for mean comparisons among the different groups.
RESULTS
In the present study, trigonelline and caffeine were found to be major components of coffee extract. The peaks shown in Fig. 1 with a retention time of 2.8 and 12.4 min were identified as trigonelline and caffeine, respectively. The content of trigonelline and caffeine obtained from the coffee extract was 4.3% and 4.9%, respectively ( Fig. 1) .
To examine the hearing sensitivity and auditory nerve conductivity after pyridoxine treatment, mice were compared using both ABR with clicks and 8 kHz TBs stimuli, along with AMLR testing. The hearing thresholds of pyridoxinetreated mice increased significantly in a dose-dependent manner in the Py-175, Py-350, and Py-700 groups by 80.1%, 65.1%, and 191.5% with clicks and by 122.8%, 140%, and 257.8% with 8 kHz TBs at 6 weeks compared with the normal group (pϽ0.05, pϽ0.01). The hearing thresholds of the pyridoxine treatment groups increased rapidly with the clicks and 8 kHz TBs between 5 and 6 weeks. Prior to 5 weeks, the hearing thresholds of the pyridoxine-treated groups exhibited no difference or very slight increases compared with the nor-mal group. The hearing thresholds of the Py-175 group were maintained or increased slightly during the experimental periods, while those of the Py-350 group increased constantly from 5 to 10 weeks. The hearing thresholds of the Py-700 group increased constantly between 6 and 9 weeks, while the last hearing tests for all mice in this group indicated deafness at 10 weeks. The Py-Coffee and Py-TRG groups suppressed the hearing threshold shift significantly for clicks and 8 kHz TBs (pϽ0.05, pϽ0.01, pϽ0.001). The hearing thresholds of the Py-Coffee and Py-TRG groups were similar or slightly shifted compared with the normal group. The normal group exhibited a mild shift in hearing thresholds with clicks and 8 kHz TBs caused by the aging effect over the 5-10-week periods. These data indicate that pyridoxine induced hearing impairment, and that coffee and trigonelline might prevent hearing impairment in the pyridoxine-induced AN mouse model (Fig. 2) . Waveforms of ABR with clicks in the normal, Py-350, Py-Coffee, and Py-TRG groups at 0, 5, and 10 weeks are shown in Fig. 3 . Positive peaks in ABR waveforms appeared at the lower stimulus intensity in the normal, Py-Coffee, and Py-TRG groups from 0 to 10 weeks into the study. However, positive peaks in ABR waveforms of the Py-350 group disappeared at the higher stimulus intensity over the course of the study.
Pyridoxine treatment significantly increased the Pa latencies of the AMLR in the Py-175, Py-350, and Py-700 groups in a dose-dependent manner by 285.2%, 463.9%, and 675.6%, respectively, at 6 weeks compared with the normal group (pϽ0.05). Pa latencies, as well as the hearing thresholds of the pyridoxine treatment groups, increased rapidly between 5 and 6 weeks. The Pa latencies of the pyridoxine treatment groups were maintained or increased slightly from 6 to 8 weeks. When compared with the Py-350 group, the Pa latencies of the Py-Coffee and Py-TRG groups decreased. The normal group exhibited a slight delay in Pa latencies caused by the aging effect over the 5-8-week period. Waveforms of AMLR in the normal, Py-350, Py-Coffee, and Py-TRG groups at 8 weeks are shown in Fig. 4(B) . In the Py-350 mouse, the Pa positive peak latency was delayed and the amplitude from the Na peak to the Pa peak decreased in AMLR waveforms compared with normal mouse. In Py-Coffee and Py-TRG mice, however, the Pa latencies and amplitude from the Na peak to the Pa peak were similar to those of the normal mouse. In the Py-175, Py-350, and Py-700 groups, increased interpeak latencies of waves I-IV exhibited 124.4%, 220.5%, and 271.8% delays with clicks, respectively, at 8 weeks in a dose-dependent manner compared with the normal group. The increased interpeak latencies of wave I-IV with 8 kHz TBs in the Py-700 group increased rapidly from 5 to 8 weeks. The interpeak latencies of waves I-IV for clicks and 8 kHz TBs tended to decrease in the Py-Coffee and Py-TRG groups compared with the Py-350 group. These latency delays in the ABR and AMLR are considered to indicate a loss of auditory nerve conductivity from the peripheral nerve to the central nerve, whereas latencies did not progress in the coffee-or trigonelline-treated mice over time (Fig. 4) .
The signal-to-noise intensities of the 3 and 4 kHz TEOAEs in the Py-350 and Py-700 groups were in the normal range at 6 weeks, with respect to the hearing threshold shifts and latency delays in the AEP, and these decreased rapidly in a dose-dependent manner between 7 and 8 weeks. At 10 weeks, 4 kHz TEOAEs in the Py-700 group gave no response in any of the mice. The intensity of the 4 kHz TEOAE did not differ among the normal, Py-Coffee, and Py-TRG groups. TEOAE results from the high-dosage pyridoxine treatment groups indicated that OHCs in the organ of Corti were functioning normally until 7 weeks after treatment. However, cochlear function in the pyridoxine-treated mice exhibited late onset damage at 8 weeks. This result indicates that the cochlear function damage was caused following auditory nerve degeneration by pyridoxine intoxication. In addition, coffee and trigonelline treatments significantly prevented these cochlear impairments (Fig. 5 ).
Histochemical examination of the auditory nerve revealed that the Py-350 group exhibited morphological differences compared with the normal group. In contrast, the auditory nerve morphologies in the Py-Coffee and Py-TRG groups were similar to those of the normal group (Fig. 6) . The most obvious difference in the Py-350 group compared with the normal group was a greater loss of myelin sheath and axon. The myelin sheath in the Py-350 group was thin and exhibited incomplete myelination. However, the myelin sheath in the Py-Coffee and Py-TRG groups appeared normal, with a thick and healthy myelin sheath. 
DISCUSSION
The present study characterized the electrophysiological and morphological consequences of pyridoxine intoxication with regard to AN over a long experimental period with high dosages of pyridoxine. Our findings demonstrate that coffee and trigonelline efficiently prevent the progress of auditory neuropathy caused by the ototoxicity of pyridoxine in mice.
A hearing threshold shift in the ABR, or a lack of response of the ABR, is a typical characteristic of AN in rodent models. 1) Increases in the latency of certain components of the ABR and AMLR also indicate an abnormal neural conduc-tance in patients with AN. [24] [25] [26] In the present study, the pyridoxine treatment groups displayed increased hearing thresholds of the ABR in proportion to the dosage of pyridoxine at 6 weeks, when clicks and 8 kHz TBs stimuli were used. Similar responses of the TEOAEs in the normal and pyridoxine treatment groups were observed at 6 weeks, indicating that OHCs in the organ of Corti were normal. The hearing thresholds of pyridoxine-treated groups increased over time. In addition, the degree of hearing impairment caused by AN was determined to be dose-dependent. In other words, low-dose pyridoxine treatment in this animal model resulted in mild AN, while high dose pyridoxine treatment produced severe Red and blue lines of ABR wave depict the ipsilateral and contralateral responses, respectively. ABR waveforms were recorded from variable intensities. The baseline in ABR is regarded under 0.12 mV of each peak amplitude, which is the optimal signal-to-noise ratio to discriminate neural activity in the auditory pathway following the sound from the background electrical activity and other bioelectric signals.
AN.
In the present study, pyridoxine intoxication delayed the Pa latencies of the AMLR and the interpeak latencies of the ABR, in proportion to the pyridoxine dosage over the experimental period. In our previous study, peak latencies of the ABR and the Pa latency of the AMLR were also found delayed in mice exhibiting diabetic AN. 27) These latency delays in the ABR and AMLR are believed to impede signal conduction along the auditory nerve due to myelin degradation. In a previous study, the morphological characteristics of fibers originating from the dorsal root ganglion (DRG) at spinal levels L4 and L5 indicated that pyridoxine induces severe loss of large and small sensory fibers in rats. 28) The results of the present study suggest that the auditory nerve undergoes severe sensory fiber loss, axonal atrophy, and degeneration in mice treated with pyridoxine, in a dose-dependent manner.
At high doses, pyridoxine causes a selective degeneration of large and small myelinated sensory axons in the peripheral nerves, 12) resulting in numbness and loss of proprioception that manifests clinically as a sensory ataxia without weakness or central nervous system dysfunction. 15) Pyridoxine treatment exhibited a curling of the toes on the hind paws, which contributed to the ataxia in rats. 29) Although Perry et al. 29) showed ataxia in rats following pyridoxine 400 mg/kg treatment, we found no ataxia or motor incoordination in mice at higher doses of pyridoxine (350, 700 mg/kg). However, some mice showed a sensitive response to contacts by hand at higher pyridoxine doses (350, 700 mg/kg). In addition, high-dose pyridoxine treatment decreased tail-flick latency compared with in the normal group of mice.
Recently, dog models at a lower dosage of pyridoxine and over shorter treatment periods displayed sensory neuropathy. 30) In rodent models, intoxication with pyridoxine causes axonal degeneration in the dorsal roots and the central projections of the same neurons in the dorsal horn of the spinal cord, while sparing the ventral roots. 31) The effect is dose dependent; at low dosages, the resultant damage occurs predominantly in the distal axon, while with progressively increasing dosages pathological abnormalities are produced in the primary neurons in the DRG. 32) AN caused by a high dosage of pyridoxine in this study reflects a similar aspect of diabetic AN in our previous study. 27) Pyridoxine has been shown to produce clear electrophysiological and anatomical deficits in the auditory nerve without overt systemic morbidity, as in diabetic neuropathy. 29) Therefore pyridoxine neuropathy as AN in this animal model could be used to evaluate peripheral neuropathy and to develop new drugs with neuroprotective properties.
Although these experimental studies provide evidence that pyridoxine-induced AN results in the degeneration of the auditory nerve, the metabolic consequences of pyridoxine toxicity remain unclear. Snodgrass 33) proposed that pyridoxine is a member of the neurotoxic pyridine family, and that pyridoxine can be converted to its active form, pyridoxal phosphate, thus acting as a biologically inactive competitive inhibitor of pyridoxal phosphate.
Coffee and trigonelline suppressed the hearing threshold shift of the ABR and recovered the delayed latencies of the AMLR and ABR induced by pyridoxine intoxication, although not to a great extent. In our previous study, coffee and trigonelline prevented hearing impairment in the diabetic AN mouse model. 22) In the present report, similar results showed that coffee and trigonelline exhibit suppression efficacy in hearing threshold shifts and latency delays caused by pyridoxine-induced AN. The coffee and trigonelline treatment groups would be expected to show fewer unmyelinated sheaths and damaged axons compared with no treatment mice. Trigonelline in coffee beans was reported as an active compound with potent neurite regeneration and synaptic reconstruction activity. 34) In rat cortical neurons, trigonelline showed dendritic and axonal regeneration. 35) A few studies have reported that nicotine causes a persistent increase of nerve growth factor (NGF) mRNA levels in the principal neurons of the hippocampus, and nicotine upregulates NGF expression and prevents apoptosis of cultured spinal cord neurons. 36, 37) Trigonelline is a nicotinic acid derivative found in coffee. Therefore we assume that coffee or trigonelline may enhance axonal regeneration and synaptic reconstruction by modulating NGF expression in pyridoxine-induced auditory neuropathy.
Because caffeine did not show significant efficacy in preventing hearing impairments in diabetic AN mouse model, 22) we did not examine the effect of caffeine on pyridoxine-induced auditory impairment. Whether caffeine prevents hearing impairment by pyridoxine-induced AN should be assessed in future studies.
The present findings demonstrate that high-dose pyridoxine administration can be used to produce a mouse model of AN, and that coffee or trigonelline as a main active compound of coffee can potentially facilitate recovery from pyridoxine-induced AN. This suggests that this newly discovered neuroprotectant (i.e., coffee and trigonelline) can be utilized for the protection of auditory systems. 
